sample of austria report
TRANSCRIPT
-
8/3/2019 Sample of Austria Report
1/6
in
LIFE
Sc enceSAUSTRIA
Al
lAbout
WhenWhat
Who
WhereHow
THE
REPORT
COMPLETE
ATHARVALIFESCIENCES
CONSULTING
ATHARVA LIFESCIENCES CONSULTING PVT. LTD.
-
8/3/2019 Sample of Austria Report
2/6
Atharva LifeSciences Consulting Pvt. Ltd. 2
foreword
Austria has a long history of lifesciences.
The interest in science can somewhat be judged by the face
that the Vienna Polytechnic Institute was set up in 1815, and
biotechnology was taught from the beginning.
Biotechnology, human medicine and medical
engineering are not only growth sectors in Eu-
rope, but are particularly booming in Austria.
Far more than one hundred companies are-
carrying out research and development work
in biotechnology. Moreover, Austria is at the
cutting edge of cancer research.
Interested in Austria as an investment desti-
nation? Heres another Atharva GloLife report
to make it easier for you!
Happy Investing!
Karnvir Singh Mundrey
Editor
Director
Atharva Lifesciences Consulting Pvt. Ltd.
-
8/3/2019 Sample of Austria Report
3/6
Atharva LifeSciences Consulting Pvt. Ltd. 3
1. INTRODUCTION ................................................................................. 6
1.1. History of Lifesciences in Austria......................................................... 7
2. LIFESCIENCES IN AUSTRIA- AN OVERVIEW .................................. 9
2.1. Biotechnology, Human Medicine and Medical ....................................
Engineering- The Leading Sectors in Austria ...................................... 10
2.2. List of Major Lifescience Events in Austria .......................................... 13
2.3. List of Major Lifescience Associations and Societies in Austria ........... 14
2.4. List of Biotech Clusters in Austria ........................................................ 16
3. INVESTMENT FACTORS ................................................................... 18
4. DOING BUSINESS IN AUSTRIA......................................................... 20
4.1. Types of Business ............................................................................... 20
4.2. Visa Requirements .............................................................................. 28
4.3. Establishing a Company ...................................................................... 30
4.4. Registering the Business ..................................................................... 31
4.5. Transferring Assets .............................................................................. 32
4.6. Business Premises .............................................................................. 33
4.7. Financing a Business .......................................................................... 34
4.8. Incentive Programs .............................................................................. 38
4.9. Employee and Social Security ............................................................. 40
5. THE TAX SYSTEM .............................................................................. 41
6. THE LEGAL FRAMEWORK ................................................................ 46
7. OPPORTUNITIES AND REQUIREMENTS ......................................... 52
8. PROFILES OF MAJOR LIFESCIENCES FIRMS ................................ 53
Table of Contents
-
8/3/2019 Sample of Austria Report
4/6
Atharva LifeSciences Consulting Pvt. Ltd. 4
Life sciences, pharmaceuticals and
biotechnology are among the most
important technological and economic
areas of the 21st century. Austria offers
networks of well-established pharmaceutical
companies, innovative biotechnology rms,leading research institutes and important
centres of expertise, providing the ideal
backdrop for a life science location of
international importance.
Life sciences are considered one of the most
promising sectors of the Austrian economy.
Austrian biotech rms are predominantly
companies with a pure research focus,
over half of which are involved in the health
sector. The most important location for lifesciences is Vienna and the surrounding
area, as it provides the ideal conditions for
this dynamic, knowledge-intensive industry.
Austria is a pioneer in cancer research.
Nationwide COMET funding program has
set up Oncotyrol, the rst K1 Center of
Excellence which will devote its efforts
over the next four years to the research
and development of excellent quality
technologies to ght cancer. It aims todevelop individual, tailor-made therapeutic
and medical treatment concepts. Moreover,
several companies belonging to the Life
Science Cluster Austria Vienna Region
(LISA VR) have come up with very promising
approaches in the search for anti-cancer
drugs.
Austrian biotech rms are among the best
in the world when it comes to developing
vaccines and new active ingredients to ght
life-threatening illnesses. A high percentage
of companies work in research and stand
at 21% research rate of the Austrian
biotechnology industry.
Many of the SMEs were founded by one
of 15 Austrian universities which are active
in the eld of biotechnology. Major biotechcompanies in Austria include Baxter, Amgen
and Novartis.
Evidence that Austrian companies are
truly world class can be seen in the
example of the Viennese biotechnology
start-up Apeiron. In 2010 they concluded
a far-reaching cooperation agreement with
the international pharmaceutical giant,
GlaxoSmithKline that covers the licensing
of new therapeutic agents, including one totreat acute respiratory distress syndrome
(ARDS).
2. LIFESCIENCES IN
AUSTRIA-AN OVERVIEW
-
8/3/2019 Sample of Austria Report
5/6
Atharva LifeSciences Consulting Pvt. Ltd. 5
Biotechnology, human medicine and medical engineering are not only growth sectors but
are particularly booming in Austria. More than one hundred companies are carrying out
research and development work in biotechnology.
Biotechnology is the integrated application of natural sciences and engineering with the
specic aim of using organisms and/or parts for the creation of products, or for their use in
different processes. Biotechnology is divided in different branches according to the different
elds of application, namely: Red Biotechnology, Green Biotechnology, Grey Biotechnology,
White Biotechnology and Blue Biotechnology.
2.1. Biotechnology, Human Medicineand Medical Engineering-
The Leading Sectors in Austria
Bio
Technology
Austriain
Green
BiotechnologyWhite
Biotechnology
Gray
Biotechnology
Blue
BiotechnologyRed
Biotechnology
-
8/3/2019 Sample of Austria Report
6/6
Atharva LifeSciences Consulting Pvt. Ltd. 6
APEPTICO Forschung Und Entwick-
lung
APEPTICO is a clinical stage bio-
tech company in Vienna, Austria.The company develops new peptide-
based medicinal drugs for the clinical
treatment of severe and chronic dis-
eases.
Their peptide molecules correspond
to validated, pharmacodynamic ac-
tive structures and domains of well-
known proteins and biopharmaceuti-cals.
All the products address highly prof-
itable and growing markets. They
collect molecular, structural, biologi-
cal & medical data of well-charac-
terised proteins and biopharmaceu-
ticals in our proprietary data base
PEPBASE(TM).
Identication of a bio-active moiety
is the rst step of PEPSCREEN(TM),
our fast-track product devel-
opment pathway. The applica-
tions PEPSCREEN(TM) and
PEPBASE(TM) in combination with
our cumulated Research & Develop-
ment experience enables to create
novel compounds which allow for in-
tellectual property protection, and fa-
cilitates lower clinical failure rates, at
reduced costs and decreased busi-
ness risks.
APEPTICOs lead molecules of the
AP301 family are synthetic peptides.
AP301 is water soluble and can be
administered into the lung by instilla-
tion or by oral inhalation.
Formulated AP301 can be nebulised
and the resulting aerosol is com-posed of peptide/water droplets of
8. PROFILES OF MAJOR
LIFESCIENCES FIRMS